Assoc. Prof. Dr. Ng Kwok Wen

Senior Lecturer, Faculty of Pharmacy


  • Ph.D (Pharmaceutical Chemistry) USM, BSc (Industrial Chemistry)


  • Academician
  • Researcher

Research Focus Area

Drug Discovery and Development, Natural Product and Herbal Medicine, Pharmaceutical Analysis, Point-of-Care Diagnostic Tool Development

  1. MM Maryan, NA. Jusril, S. Imran, M.I. Adenan, And K.W. Ng. 2021. In Silico Identification Of APOBEC3B Small Molecule Inhibitors From DTP-NCILibraries. International Journal of Applied Pharmaceutics, 13 (3).
  2. MM Maryan, NA. Jusril, M.I. Adenan, And K.W. Ng. 2020. Molecular Docking Based On In Silico Screening Of NCI Diversity Sets For Potent Inhibitors Of Apobec3A Enzyme. International Journal of Medical Toxicology & Legal Medicine Vol. 23(1): 138-144.
  3. DSS. Song, S.W. Leong, K.W. Ng, F. Abas, K. Shaari, C.O. Leong, F.F. Chung, C.W. Mai, L.W. Hii, P.J. Tan, V. Patel. 2019. Novel 2-Benzoyl-6-(2,3 Dimethoxybenzylidene)-Cyclohexenol Confers Selectivity toward Human MLH1 Defective Cancer Cells through Synthetic Lethality. SLAS Discovery. Jun;24(5):548-562.
  4. M.Z.H. Fadlullah, I.K. Chiang, K.R. Dionne, P.S. Yee, C.P. Gan, K.K. Sam, V.K.H. Tiong, A.K.W.Ng, D. Martin, K.P. Lim, T.G. Kallarakkal, W.M.W. Mustafa, M.T. Abraham, R.B. Zain, Z.A. Abdul Rahman, A. Molinolo, V.Patel, J.S. Gutkind, A.C. Tan, S.C. Cheong.. 2016 Genetically defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies. Oncotarget.

  • Registered Chemist, Malaysia Institute of Chemistry
  • Associate Member, American Association for Cancer Research

  • Head of Pharmaceutical Chemistry, School of Pharmacy, Management and Science University.
  • Senior Lecturer, Centre for Foundation Studies, Faculty of Applied Science, UiTM Selangor.
  • Post-Doctoral Scientist, Drug Discovery Unit, Cancer Research Malaysia.
  • Research Fellow, Universiti Sains Malaysia

  • Pharmaceutical Chemistry
  • Medicinal Chemistry
  • Pharmaceutical Analysis
  • Pharmacognosy
  • Organic and Inorganic Chemistry

  • NA. Jusril, S.I.A. Bakar, M.I.Adenan , K.W. Ng. Molecular Docking studies for the Identification of Novel APOBEC3B Inhibitors using Different Docking Routines. International conference on drug discovery and translational medicine 2018 (ICDDTM '18). Putrajaya, Malaysia.
  • NA. Jusril, S.I.A. Bakar, M.I.Adenan , K.W. Ng. Novel APOBEC3B Inhibitors through in-silico approaches. ASiD Conference (ASiDCON2018). Dengkil, Malaysia
  • K.W. Ng, K.S. Lee, V. Patel, E. Sundaramoorthy, N. Ayoub, X. Su, A.Venkitaraman, S.H. Teo. Development Identification of synthetic lethality drug compounds from natural products for non-druggable cancers. AACR-NCI-EORTC Symposium 2014, Barcelona, Spain.
  • K.H. Tiong, M.Z.H. Fadlullah, A. Ng, R. Zain, M.T. Abraham, Z.A. Abdul Rahman, V. Patel, S.C. Cheong. Next-generation sequencing reveals clinically relevant genetic signatures for the identification of novel therapeutics for oral cancer. Precision Medicine for Cancer. 2015, Luxembourg.

Scan WeChat QR Code

Scan WeChat QR Code